
2,3-Butanedione monoxime
CAS:
Ref. 3D-FB32378

Produktinformation
- Diacetylmonoxime
2,3-Butanedione monoxime (BDM) is a metabolite of the glycol ether, 2,3-butanedione. It has been shown to have a beneficial effect on metabolic disorders in rats by modulating several enzyme activities. The optimum concentration of BDM is 2 mmol/L. This compound has also been shown to inhibit the oxidation of xanthine oxidase and the formation of hydroxyl radicals in vitro. BDM has also been found to have synchronous fluorescence with papillary muscles from guinea pigs and cytosolic ca2+ levels in rat liver cells. The structure analysis revealed that BDM binds to the active site of the x-ray crystal structures for mitochondrial cytochrome C oxidase and cardiac ATP synthase with an affinity similar to that of CoQ10. The Langmuir adsorption isotherm for BDM was calculated as 0.913 +/- 0.034 cm/g at 20 degrees Celsius,
Chemische Eigenschaften
Technische Anfrage zu: 2,3-Butanedione monoxime
Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern